睿智生物科学 RGC
$5.27 +$0.00 (0.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $5.44 +3.23%
开盘$5.36
昨收$5.27
当日区间$5.10 – $5.48
成交量207.8K
市值$2.61B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q4, ended Dec 2017
营收$861.60M+6.0% YoY
营业利润$90.70M-4.5% YoY
净利润$28.90M-46.4% YoY
摊薄每股收益$0.19-44.1% YoY
自由现金流$79.40M-22.8% YoY
经营现金流$154.30M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率62.4%
营业利润率10.5%
净利率3.4%
净资产收益率-128.5%
资产收益率-114.2%
投入资本回报率-122.9%
流动比率10.77
负债/资产比率9.4%
现金及投资$14.19M
总负债$59,499.00
净现金（净负债）$14.13M
利润表
| 项目 | 2026 ANNUAL | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $11.72M | $3.77M | $4.74M | $6.27M | $7.62M |
| 销售及管理费用 | $10.42M | $2.82M | $3.67M | $4.69M | $5.11M |
| -销售及营销费用 | $6,486.00 | $8,014.00 | $125,427.00 | $262,664.00 | $25,275.00 |
| -管理费用 | $10.42M | $2.81M | $3.55M | $4.43M | $5.08M |
| 研发费用 | $1.30M | $948,289.00 | $1.07M | $1.58M | $2.51M |
| 营业利润 | -$11.72M | -$3.77M | -$4.74M | -$6.27M | -$7.62M |
| 其他收入（支出） | $22,520.00 | $185,772.00 | $373,505.00 | $211,342.00 | $23,215.00 |
| 其他非经营性收入（支出） | $22,520.00 | $185,772.00 | $373,505.00 | $211,342.00 | $23,215.00 |
| 税前利润 | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M |
| 持续经营利润 | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M |
| 少数股东权益 | $0.00 | $0.00 | -$61,384.00 | -$191,199.00 | -$148,612.00 |
| 归属母公司净利润 | -$11.70M | -$3.58M | -$4.30M | -$5.87M | -$7.45M |
| 归属普通股股东净利润 | -$11.70M | -$3.58M | -$4.30M | -$5.87M | -$7.45M |
| 基本每股收益 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
| 摊薄每股收益 | -$0.02 | -$0.01 | -$0.01 | -$0.01 | -$0.02 |
资产负债表
| 项目 | 2026 ANNUAL | 2026 Q4 | 2026 Q2 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $14.73M | $14.73M | $3.01M | $5.76M | $5.76M |
| 流动资产合计 | $14.22M | $14.22M | $2.36M | $4.90M | $4.90M |
| 现金及现金等价物与短期投资 | $14.19M | $14.19M | – | $4.90M | $4.90M |
| -现金及现金等价物 | $14.19M | $14.19M | – | $2.42M | $2.42M |
| -短期投资 | $0.00 | $0.00 | – | $2.48M | $2.48M |
| 应收款 | $30,702.00 | $30,702.00 | – | $5,798.00 | $5,798.00 |
| -其他应收款 | $30,702.00 | $30,702.00 | – | $5,798.00 | $5,798.00 |
| 非流动资产合计 | $506,402.00 | $506,402.00 | $656,170.00 | $852,769.00 | $852,769.00 |
| 固定资产净值 | $430,732.00 | $430,732.00 | – | $759,819.00 | $759,819.00 |
| -固定资产原值 | $1.37M | $1.37M | – | $1.62M | $1.62M |
| -累计折旧 | -$938,959.00 | -$938,959.00 | – | -$857,267.00 | -$857,267.00 |
| 一年以上预付资产 | $75,670.00 | $75,670.00 | – | $92,950.00 | $92,950.00 |
| 负债合计 | $1.38M | $1.38M | $1.79M | $895,308.00 | $895,308.00 |
| 流动负债合计 | $1.32M | $1.32M | – | $663,673.00 | $663,673.00 |
| 应付款 | $10,787.00 | $10,787.00 | – | $2,539.00 | $2,539.00 |
| -一年内应付关联方款项 | $10,787.00 | $10,787.00 | – | $2,539.00 | $2,539.00 |
| 一年内应计费用 | $1.07M | $1.07M | – | $348,354.00 | $348,354.00 |
| 短期债务及融资租赁负债 | $236,312.00 | $236,312.00 | – | $312,780.00 | $312,780.00 |
| -一年内到期融资租赁负债 | $236,312.00 | $236,312.00 | – | $312,780.00 | $312,780.00 |
| 非流动负债合计 | $59,499.00 | $59,499.00 | – | $231,635.00 | $231,635.00 |
| 长期债务及融资租赁负债 | $59,499.00 | $59,499.00 | – | $231,635.00 | $231,635.00 |
| -长期融资租赁负债 | $59,499.00 | $59,499.00 | – | $231,635.00 | $231,635.00 |
| 股东权益合计 | $13.35M | $13.35M | $1.22M | $4.86M | $4.86M |
| 股东权益 | $13.35M | $13.35M | $1.22M | $4.86M | $4.86M |
| 股本 | $4,959.00 | $4,959.00 | – | $4,945.00 | $4,945.00 |
| -普通股 | $4,959.00 | $4,959.00 | – | $4,945.00 | $4,945.00 |
| 资本公积 | $50.29M | $50.29M | – | $30.12M | $30.12M |
| 留存收益 | -$36.90M | -$36.90M | – | -$25.20M | -$25.20M |
| 不影响留存收益的损益 | -$45,262.00 | -$45,262.00 | – | -$64,786.00 | -$64,786.00 |
| 少数股东权益 | $0.00 | $0.00 | – | $0.00 | $0.00 |
| 其他非流动资产 | – | – | $656,170.00 | – | – |
现金流量表
| 项目 | 2026 ANNUAL | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL |
|---|---|---|---|---|---|
| 经营活动现金流 | -$7.70M | -$3.11M | -$4.00M | -$4.96M | -$5.27M |
| 持续经营经营活动现金流净额 | -$7.70M | -$3.11M | -$4.00M | -$4.96M | -$5.27M |
| 持续经营净利润 | -$11.70M | -$3.58M | -$4.36M | -$6.06M | -$7.59M |
| 折旧、折耗与摊销 | $404,543.00 | $392,743.00 | $745,588.00 | $769,687.00 | $604,397.00 |
| 其他非现金项目 | -$22,520.00 | -$185,772.00 | -$248,000.00 | -$85,400.00 | -$10,733.00 |
| 营运资金变动 | $398,805.00 | $18,858.00 | -$585,365.00 | -$508,945.00 | -$1.02M |
| -预付资产变动 | -$11,242.00 | $151,714.00 | -$85,415.00 | -$23,147.00 | -$104,625.00 |
| -应付账款及应计费用变动 | $733,490.00 | $217,122.00 | -$34,880.00 | $1,874.00 | -$489,025.00 |
| -其他流动负债变动 | -$323,443.00 | -$349,978.00 | -$465,070.00 | -$487,672.00 | -$430,421.00 |
| 投资活动现金流净额 | $2.50M | $2.69M | $5.24M | $58,978.00 | -$10.78M |
| 持续经营投资活动现金流净额 | $2.50M | $2.69M | $5.24M | $58,978.00 | -$10.78M |
| 固定资产购置及出售净额 | $0.00 | -$152,689.00 | -$5,376.00 | -$26,422.00 | -$780,876.00 |
| 投资购置及出售净额 | $2.50M | $2.84M | $5.25M | $85,400.00 | -$10.00M |
| 筹资活动现金流 | $16.95M | $0.00 | $102,282.00 | $134,913.00 | $22.41M |
| 持续经营筹资活动现金流净额 | $16.95M | $0.00 | $102,282.00 | $134,913.00 | $22.41M |
| 普通股发行净额 | $18.62M | $0.00 | $0.00 | – | $22.67M |
| 股票期权行使所得 | $102,561.00 | $0.00 | $0.00 | – | – |
| 其他筹资费用净额 | -$1.78M | – | $102,282.00 | $134,913.00 | $164,000.00 |
| 期末现金余额 | $14.19M | $2.42M | $2.96M | $1.56M | $6.42M |
| 现金净变动 | $11.75M | -$427,360.00 | $1.34M | -$4.77M | $6.36M |
| 期初现金余额 | $2.42M | $2.96M | $1.56M | $6.42M | $59,413.00 |
| 汇率变动影响 | $18,907.00 | -$114,760.00 | $53,221.00 | -$83,145.00 | $0.00 |
| 自由现金流 | -$7.70M | -$3.27M | -$4.01M | -$4.99M | -$6.05M |
| 持续经营损益 | – | – | – | $1,415.00 | – |
| 债务发行及偿还净额 | – | – | – | – | -$431,969.00 |
暂无评论——快来第一个聊聊 RGC。
登录后参与讨论。